Add to favorite
Subscribe to our Newsletters Subscribe to our Newsletters Get Daily Updates RSS

Tumor Versus Tumor
before March 9, 2006


One of the reasons for tumor uncontrolled growth is that cancer cells are almost invisible for immune system. For patient’s organism successful fight against the tumor, scientists try to make the tumor “visible” – to mark its surface with antigens causing explosive immune response. Such modified cancer cells could serve as a vaccine for an ordinary, non-modified tumor, because then activated immune system will inhibit tumor growth. Scientists from RAMS Science Hematology Centre have attempted to develop such antitumor vaccine. As an antigen that whips immune system, the researchers have used a protein of Newcastle disease virus coating.

Newcastle disease is a serious bird disease, which is impossible to cure. When this disease, also known as Asiatic cholera, appears on a bird farm, all livestock has to be killed. Newcastle disease virus is a strongest stimulant for mammalian immune system. In order to develop antitumor vaccine the scientists have chosen a viral coat protein, hemagglutinin neuraminidase (HN). They have inserted HN-containing constraint to mice myeloma cells and got the cell line that synthesizes viral protein. This line was used as a vaccine. The cells were first irradiated with radioactive Cs (to prevent vaccine tumor from growing in the organism) and then introduced intraperitoneally to mice. Other animals were given injections of irradiated, but non-modified, tumor or tumor, infected with intact Newcastle virus. Each mouse has received one million cells. After three days, the original tumor was transplanted under the skin between the shoulders of every mouse (4000 thousand cells of mice myeloma) and has been observed and measured for 21 day. The researches have chosen this period because then animals start suffering from tissue necrosis and ulceration. Then the tumor was pulled out and weighed.

Organisms of mice, which were preliminary immunized with HN-containing tumor, were desperately fighting myeloma growth. The tumor weight was 3-15 times lower than that of mice vaccinated with ordinary tumor or culture medium. Intact Newcastle disease virus doesn’t stop tumor growth, and sometimes even worsens the situation. And hemagglutinin neuraminidase is just what the doctor ordered. According to the scientists, introduction of this gene to the tumor led to development of the vaccine, effective and safe for the patient. This constraint can by used to modify any tumor, not only myeloma. Unfortunately, immunotherapy is effective for curing only small tumors, thus this vaccine is effective only during early stages of the disease.

Tags: Russian medicine     

Next Previous

You might also find interesting:

"Helium Facilitates Breathing"- Russian Scientist on the Treatment of Pulmonary Failure with COVID-19 Treatment Of Children With Hereditary Diseases Science Increases Oil Production Efficiency Cell Therapy to Fight Traumatic Coma Experts: Cancer Treatment without Chemotherapy Poisoning Strengthens Credibility of Russian Science

Comment on our site

RSS   twitter      submit

Russian tourist destinations  ecology  Life Saving  Andrei Sakharov  Igor Moiseyev   Apollon Maykov  Russian Nature  Russian sport  Alexei Navalny  emigration  Zhukovsky  Russian Internet blacklist  Russian Cinema  Russian business  Phobos Soil  Russian science  Moscow Zoo  Fyodor Shalyapin  Siberia  Christianity  Robots  Fountains of St. Petersburg  Ukraine crisis  Gorky Park  Moscow  Folk Arts  Nature Reserves  Quantum Physics  Military festival  Arkady Rylov  Russian tourism  Kaliningrad  Russian sportswomen  Duty Free  Exhibitions in Moscow  Muslim  Early Music Festival  airport transfer in Russia  Russian scientists  Russian economy  Tomsk  Russian oil companies  French Chanson  Rubles Fall  Russian places of interest  Boris Nemtsov  Left Front  Mercedes-Benz Fashion Week Russia  Azerbaijan  St. Petersburg 

Travel Blogs
Top Traveling Sites